An interventional study of IVR call/text and Email in Asthma, sponsored by National Jewish Health. Completed at 1 site in United States. Open to participants aged 19 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-11-09.
Sponsored by National Jewish Health · Not applicable, Interventional, and Health services research
The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.
Breathe Well uses the Kaiser Permanente Electronic Health Record (EHR) to identify asthma exacerbation risk factors. For patients with a history of frequent exacerbations or B-agonist overuse, the EHR notifies a nurse who uses an EHR-generated tailored clinical report and patient directed decision support tool to engage and empower patients to develop an action plan in collaboration with providers. EHR-templated notes and order sets facilitate care plan execution. Poor controller medication adherence or unaddressed smoking results in the patient being automatically enrolled in an IBCT medication refill or smoking cessation program. Breathe Well uses multiple EHR functions and a patient and provider team to address barriers to evidence-based asthma care for providers.The study will be conducted in 26 primary care clinics of Kaiser Permanente Colorado (KPCO) using a pragmatic clinical trial design. Up to 15,000 high-risk asthma patients will be assigned to Breathe Well or guideline-based usual care based on their clinic.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 14,978 is above the median of 83 across 2,752 interventional studies indexed under Asthma.
Browse Asthma studies →National Jewish Health is the lead sponsor of 108 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria: Adults with ≥1 EHR of these indicators of an asthma care gap in the EHR will be eligible.
Exclusion Criteria:
Identify gaps in care and contact patients by IVR phone call or text
Behavioral: IVR call/text
Identify gaps in care and contact patients by email
Behavioral: Email
For patients under filling their inhaled corticosteroid or overusing B-agonist, the patient is contacted via IVR call or text
Patients under filling their inhaled corticosteroid or overusing B-agonist, the the patient is contacted via email
Asthma Exacerbations
Defined as number of urgent care visits, hospitalizations, or prescriptions of an oral corticosteroid
Time frame: 12 months
Controller medication adherence
Days of medication possession will be calculated for each patient
Time frame: 12 months
Plan to share: Undecided
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Jewish Health